195 related articles for article (PubMed ID: 35595309)
1. STAT3 Activates the Pentraxin 3 Gene in Chronic Lymphocytic Leukemia Cells.
Rozovski U; Veletic I; Harris DM; Li P; Liu Z; Jain P; Manshouri T; Ferrajoli A; Burger JA; Bose P; Thompson PA; Jain N; Wierda WG; Verstovsek S; Keating MJ; Estrov Z
J Immunol; 2022 Jun; 208(12):2847-2855. PubMed ID: 35595309
[TBL] [Abstract][Full Text] [Related]
2. Stat3 activates the receptor tyrosine kinase like orphan receptor-1 gene in chronic lymphocytic leukemia cells.
Li P; Harris D; Liu Z; Liu J; Keating M; Estrov Z
PLoS One; 2010 Jul; 5(7):e11859. PubMed ID: 20686606
[TBL] [Abstract][Full Text] [Related]
3. STAT3-Induced Wnt5a Provides Chronic Lymphocytic Leukemia Cells with Survival Advantage.
Rozovski U; Harris DM; Li P; Liu Z; Jain P; Ferrajoli A; Burger JA; Bose P; Thompson PA; Jain N; Wierda WG; Uziel O; Keating MJ; Estrov Z
J Immunol; 2019 Dec; 203(11):3078-3085. PubMed ID: 31645416
[TBL] [Abstract][Full Text] [Related]
4. STAT3 induces the expression of GLI1 in chronic lymphocytic leukemia cells.
Rozovski U; Harris DM; Li P; Liu Z; Jain P; Manshouri T; Veletic I; Ferrajoli A; Bose P; Thompson P; Jain N; Verstovsek S; Wierda W; Keating MJ; Estrov Z
Oncotarget; 2021 Mar; 12(5):401-411. PubMed ID: 33747356
[TBL] [Abstract][Full Text] [Related]
5. STAT3-activated GM-CSFRα translocates to the nucleus and protects CLL cells from apoptosis.
Li P; Harris D; Liu Z; Rozovski U; Ferrajoli A; Wang Y; Bueso-Ramos C; Hazan-Halevy I; Grgurevic S; Wierda W; Burger J; O'Brien S; Faderl S; Keating M; Estrov Z
Mol Cancer Res; 2014 Sep; 12(9):1267-82. PubMed ID: 24836891
[TBL] [Abstract][Full Text] [Related]
6. At High Levels, Constitutively Activated STAT3 Induces Apoptosis of Chronic Lymphocytic Leukemia Cells.
Rozovski U; Harris DM; Li P; Liu Z; Wu JY; Grgurevic S; Faderl S; Ferrajoli A; Wierda WG; Martinez M; Verstovsek S; Keating MJ; Estrov Z
J Immunol; 2016 May; 196(10):4400-9. PubMed ID: 27076684
[TBL] [Abstract][Full Text] [Related]
7. Obesity-associated metabolic inflammation promotes triple-negative breast cancer progression through the interleukin-6/STAT3/pentraxin 3/matrix metalloproteinase 7 axis.
Xie H; Ruan G; Wei L; Zhang H; Shi J; Lin S; Liu C; Liu X; Zheng X; Chen Y; Deng L; Shi H
Int Immunopharmacol; 2024 Jul; 136():112332. PubMed ID: 38805776
[TBL] [Abstract][Full Text] [Related]
8. STAT3-induced SMYD3 transcription enhances chronic lymphocytic leukemia cell growth in vitro and in vivo.
Lin F; Wu D; Fang D; Chen Y; Zhou H; Ou C
Inflamm Res; 2019 Sep; 68(9):739-749. PubMed ID: 31218443
[TBL] [Abstract][Full Text] [Related]
9. Signal transducer and activator of transcription-3 induces microRNA-155 expression in chronic lymphocytic leukemia.
Li P; Grgurevic S; Liu Z; Harris D; Rozovski U; Calin GA; Keating MJ; Estrov Z
PLoS One; 2013; 8(6):e64678. PubMed ID: 23750211
[TBL] [Abstract][Full Text] [Related]
10. Aberrant LPL Expression, Driven by STAT3, Mediates Free Fatty Acid Metabolism in CLL Cells.
Rozovski U; Grgurevic S; Bueso-Ramos C; Harris DM; Li P; Liu Z; Wu JY; Jain P; Wierda W; Burger J; O'Brien S; Jain N; Ferrajoli A; Keating MJ; Estrov Z
Mol Cancer Res; 2015 May; 13(5):944-53. PubMed ID: 25733697
[TBL] [Abstract][Full Text] [Related]
11. Multimer formation and ligand recognition by the long pentraxin PTX3. Similarities and differences with the short pentraxins C-reactive protein and serum amyloid P component.
Bottazzi B; Vouret-Craviari V; Bastone A; De Gioia L; Matteucci C; Peri G; Spreafico F; Pausa M; D'Ettorre C; Gianazza E; Tagliabue A; Salmona M; Tedesco F; Introna M; Mantovani A
J Biol Chem; 1997 Dec; 272(52):32817-23. PubMed ID: 9407058
[TBL] [Abstract][Full Text] [Related]
12. STAT3 and NF-κB cooperatively control in vitro spontaneous apoptosis and poor chemo-responsiveness in patients with chronic lymphocytic leukemia.
Liu FT; Jia L; Wang P; Wang H; Farren TW; Agrawal SG
Oncotarget; 2016 May; 7(22):32031-45. PubMed ID: 27074565
[TBL] [Abstract][Full Text] [Related]
13. STAT3 is constitutively phosphorylated on serine 727 residues, binds DNA, and activates transcription in CLL cells.
Hazan-Halevy I; Harris D; Liu Z; Liu J; Li P; Chen X; Shanker S; Ferrajoli A; Keating MJ; Estrov Z
Blood; 2010 Apr; 115(14):2852-63. PubMed ID: 20154216
[TBL] [Abstract][Full Text] [Related]
14. Endothelial cell-derived pentraxin 3 limits the vasoreparative therapeutic potential of circulating angiogenic cells.
O'Neill CL; Guduric-Fuchs J; Chambers SE; O'Doherty M; Bottazzi B; Stitt AW; Medina RJ
Cardiovasc Res; 2016 Dec; 112(3):677-688. PubMed ID: 27659714
[TBL] [Abstract][Full Text] [Related]
15. Pentraxin 3 acts as a functional effector of Akt/NF-κB signaling to modulate the progression and cisplatin-resistance in non-small cell lung cancer.
Li Y; Song X; Niu J; Ren M; Tang G; Sun Z; Kong F
Arch Biochem Biophys; 2021 Apr; 701():108818. PubMed ID: 33617838
[TBL] [Abstract][Full Text] [Related]
16. Constitutive Phosphorylation of STAT3 by the CK2-BLNK-CD5 Complex.
Rozovski U; Harris DM; Li P; Liu Z; Jain P; Veletic I; Ferrajoli A; Burger J; O'Brien S; Bose P; Thompson P; Jain N; Wierda W; Keating MJ; Estrov Z
Mol Cancer Res; 2017 May; 15(5):610-618. PubMed ID: 28130399
[TBL] [Abstract][Full Text] [Related]
17. Inducible expression of the long pentraxin PTX3 in the central nervous system.
Polentarutti N; Bottazzi B; Di Santo E; Blasi E; Agnello D; Ghezzi P; Introna M; Bartfai T; Richards G; Mantovani A
J Neuroimmunol; 2000 Jul; 106(1-2):87-94. PubMed ID: 10814786
[TBL] [Abstract][Full Text] [Related]
18. Expression of long pentraxin 3 in human nasal mucosa fibroblasts, tissues, and secretions of chronic rhinosinusitis without nasal polyps.
Tsai YJ; Hao CY; Chen CL; Wu PH; Wu WB
J Mol Med (Berl); 2020 May; 98(5):673-689. PubMed ID: 32239253
[TBL] [Abstract][Full Text] [Related]
19. Macrophage expression and prognostic significance of the long pentraxin PTX3 in COVID-19.
Brunetta E; Folci M; Bottazzi B; De Santis M; Gritti G; Protti A; Mapelli SN; Bonovas S; Piovani D; Leone R; My I; Zanon V; Spata G; Bacci M; Supino D; Carnevale S; Sironi M; Davoudian S; Peano C; Landi F; Di Marco F; Raimondi F; Gianatti A; Angelini C; Rambaldi A; Garlanda C; Ciccarelli M; Cecconi M; Mantovani A
Nat Immunol; 2021 Jan; 22(1):19-24. PubMed ID: 33208929
[TBL] [Abstract][Full Text] [Related]
20. CD5 promotes IL-10 production in chronic lymphocytic leukemia B cells through STAT3 and NFAT2 activation.
Garaud S; Morva A; Lemoine S; Hillion S; Bordron A; Pers JO; Berthou C; Mageed RA; Renaudineau Y; Youinou P
J Immunol; 2011 Apr; 186(8):4835-44. PubMed ID: 21398617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
